Akorn Inc
Jan 02, 2009 at 13:18
Apr 25, 2008 at 12:40
Mar 12, 2008 at 18:43
Jul 18, 2007 at 13:50
Dec 07, 2006 at 16:34
Photos »
/ 
News across the web »
Feb 25, 2012 at 00:56 | Source: Business Standard
Jan 20, 2012 at 13:25 | Source: Money Rediff News Report
Jan 20, 2012 at 01:11 | Source: Business Standard
Jan 19, 2012 at 19:12 | Source: Economic Times
Interact & exchange stock tips & market info »
Kilitch Drugs (India) today said it had signed an agreement to sell it...
10.53 AM Oct 10th 2011
Kilitch Drugs has proposed to sell its business of research, developme...
10.32 AM Oct 10th 2011
Mumbai: Kilitch Drugs (India) today said it has signed an agreement to...
10.17 AM Oct 10th 2011
Related News »
Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology.
May 22, 2012 at 18:30 | Source: Financial News Network Online
Friday, May 18, 2012... Akorn Inc. (NASDAQ: AKRX) closed Thursday's trading session at $12.88. In the past year, the stock has hit a 52-week low of $6.18 and 52-week high of..... Monday, May 14, 2012... Akorn (NASDAQ:AKRX) closed Friday's meandering ...
May 24, 2012 at 12:01 | Source: Market Intelligence Center
Thursday, May 24, 2012... Akorn Inc. (NASDAQ: AKRX) closed Wednesday's trading session at $13.60. In the past year, the stock has hit a 52-week low of $6.18 and 52-week high..... Friday, May 18, 2012... Akorn Inc. (NASDAQ: AKRX) closed Thursday's trading ...
May 14, 2012 at 11:45 | Source: Market Intelligence Center
Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology.
May 15, 2012 at 16:01 | Source: comcast.net
Pharmacyclics Inc, and Akorn, Inc. Investors are buying the stock and pushing it higher because they may think that these stocks were undervalued. This could be a result of higher than expected earnings, overall market growth, or simply investor speculation.
May 22, 2012 at 14:48 | Source: takeoverchatter.com
Stocks hitting new 52 week highs on May 15 are Akorn, Inc, Snyder's-Lance, Inc, Vertex Pharmaceuticals Incorporated, Air Methods Corp, and Churchill Downs Inc. Investors are buying the stock and pushing it higher because they may think that these stocks were undervalued.
May 15, 2012 at 16:44 | Source: takeoverchatter.com
Akorn, Inc. has a Return on Equity of 34.73% and Return on Assets of 20.58% and 1-Year Projected Earnings Per Share Growth Rate of 28.57%. The short interest was 13.61% as of 05/24/2012. Akorn, Inc. engages in the manufacture and marketing of diagnostic ...
May 24, 2012 at 21:05 | Source: Seekingalpha.com
The longest losing streak lasted 2 days (i.e. a win streak / losing streak ratio of 5.5). 3. Akorn, Inc. (AKRX): Engages in the manufacture and marketing of diagnostic and therapeutic pharmaceutical products, hospital drugs, and injectable pharmaceuticals ...
May 23, 2012 at 04:17 | Source: Seekingalpha.com
Fresenius Kabi Pharmaceuticals Holding, Inc. does not assume any obligation to update or ... Cogentin(R) is a registered trademark of Akorn. Keppra(R) is a registered trademark of UCB Pharma, S.A.. Cyklokapron(R) is a registered trademark ...
May 23, 2012 at 12:17 | Source: Marketwatch
Advanced Energy Systems Inc AeroVironment Inc Agilent Technologies Inc AirBoss Defense AirBoss of America Corporation Akorn Inc Alfred Krcher GmbH & Co KG Allen-Vanguard Corporation AMETEK Inc Applied Research Associates Inc (ARA) Argon Electronics LLP ...
May 14, 2012 at 15:12 | Source: CNBC